Isabelle Aubry
- Rheumatology top 10%
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents 3
- Ophthalmology top 10%
- Retinal Diseases and Treatments 3
-
- Galectins and Cancer Biology 6
-
- Protein Tyrosine Phosphatases 14
- RNA modifications and cancer 3
- Bone Metabolism and Diseases 2
-
- Cytokine Signaling Pathways and Interactions 4
- Bone health and treatments 2
- Co-authors
- Michel L. TremblayDaniel LajeunesseAline DelalandreJean‐Pierre PelletierJohanne Martel‐PelletierMartin LavigneDenis CouchourelAbhijeet S. Kate
- Cited by
- RheumatologyToxicologyOphthalmology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)PLoS ONE (1 paper)
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
Isabelle Aubry
25 papers receiving 465 citations
Peers
Comparison fields: 5 of 73
- Rheumatology 113
- Toxicology 22
- Ophthalmology 43
- Immunology 91
- Molecular Biology 233
Countries citing papers authored by Isabelle Aubry
This map shows the geographic impact of Isabelle Aubry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Aubry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Aubry more than expected).
Fields of papers citing papers by Isabelle Aubry
This network shows the impact of papers produced by Isabelle Aubry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Aubry. The network helps show where Isabelle Aubry may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Isabelle Aubry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 15 | |
| 8 | 2022 | 12 | |
| 9 | 2021 | 9 | |
| 10 | 2020 | 10 | |
| 11 | 2019 | 28 | |
| 12 | 2017 | 10 | |
| 13 | 2017 | 17 | |
| 14 | 2016 | 15 | |
| 15 | 2015 | 17 | |
| 16 | 2014 | 26 | |
| 17 | 2009 | 114 | |
| 18 | 2006 | 30 | |
| 19 | 2006 | 47 | |
| 20 | 1993 | 28 |
About Isabelle Aubry
Isabelle Aubry is a scholar working on Toxicology, Immunology and Ophthalmology, having authored 26 papers that have together received 468 indexed citations. Recurring topics across this work include Protein Tyrosine Phosphatases (14 papers), Galectins and Cancer Biology (6 papers), Cytokine Signaling Pathways and Interactions (4 papers), Bioactive Compounds and Antitumor Agents (3 papers), Retinal Diseases and Treatments (3 papers), RNA modifications and cancer (3 papers), Bone Metabolism and Diseases (2 papers) and Bone health and treatments (2 papers). The work is most often cited by research in Rheumatology (113 citations), Toxicology (22 citations) and Ophthalmology (43 citations). Isabelle Aubry has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Michel L. Tremblay, Daniel Lajeunesse, Aline Delalandre, Jean‐Pierre Pelletier, Johanne Martel‐Pelletier, Martin Lavigne, Denis Couchourel, Abhijeet S. Kate, Russell G. Kerr and Julio Fernandes. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.